A clinical-stage company
Xenas Biopharma raises $225 mln in US IPO, ET HealthWorld
Article Partner
London: Immunology-based therapy developer Xenas Biopharma on Thursday said it has raised $225 million in its US initial public offering ...
most recent
Special Stories, Trending
Why is Gambhir’s old dressing room statement going viral, claims are being made about Sarfraz Khan
Special Stories, Trending
BSNL users are getting 2.5GB data per day for Rs 225 with unlimited calling for 30 days.
